By using antibodies directed against gapjunction proteins of liver (connexins 26 and 32) and heart (connexin 43), we have localized immunoreactivity to specific cell types in frozen sections of adult rodent brains. Connexin 32 reactivity was found in oligodendrocytes and also in a few neurons, whereas reactivity to connexins 26 and 43 was localized to leptomeningeal cells, ependymal cells, and pineal gland. Immunoreactivity with antibodies to connexin 43 also occurred in astrocytes. Furthermore, during embryonic and postnatal maturation of brain tissues, gap junction proteins were differentially expressed. Connexins 43 and 26 predominated in the neuroepithelium of embryonic brains, whereas connexin 32 was virtually absent. Between 3 and 6 weeks after birth, connexin 26 largely disappeared from immature brain; this time course corresponded to the increased expression of connexin 32. Expression of connexin 43 remained high throughout embryonic and postnatal development. These findings demonstrate that gap junction expression in the brain is diverse, with specific cell types expressing different connexins; this cell-specific distribution may imply differences in the function of these intercellular channels in different loci and developmental stages.Gap junctions are the structural domains through which electrical transmission and metabolic and ionic cooperation between contiguous cells are thought to be mediated. Recent progress in the understanding of the molecular composition of at least four types of gapjunctions found in liver, heart, and lens fibers has been derived from immunochemical (1-5) and molecular biological studies (6-10). The message emerging from these discoveries is that gap junctions are composed of a family of homologous proteins that are expressed in various amounts in different cell types (11,12). We have shown (11, 12) that at least two gap junction proteins are present in liver.Nervous tissue was among the first organs where gap junction membrane contacts were structurally and physiologically characterized (for review, see ref. 13). Recent studies using antibodies against multiple determinants have demonstrated that gap junctions are abundant in brain (14,15), but the composition of these gap junction proteins was not unambiguously determined.By using affinity-purified polyclonal and monoclonal anticonnexin-32 antibodies, an antibody to the liver protein connexin 26, and a polyclonal antibody directed to the carboxylterminal domain of the heart protein connexin 43, we have evaluated the patterns of expression of these proteins in adult and embryonic brains. Our data provide evidence that specific sets of gap junction proteins are expressed by specific brain cell populations. In addition, we found that during development relative amounts of connexin 26 and connexin 32 shift. Connexin 26, which is abundant in embryonic brain, becomes confined to leptomeningeal and ependymal cells and to pinealocytes. Connexin 32, which is not expressed to a large extent in embryonic brain, is expressed ...

The gap junctional protein connexin32 is expressed in hepatocytes, exocrine pancreatic cells, Schwann cells, and other cell types. We have inactivated the connexin32 gene by homologous recombination in the mouse genome and have generated homozygous connexin32-deficient mice that were viable and fertile but weighed on the average -17% less than wild-type controls. Electrical stimulation of sympathetic nerves in connexin32-deficient liver triggered a 78% lower amount of glucose mobilization from glycogen stores, when compared with wild-type liver. Thus, connexin32-containing gap junctions are essential in mouse liver for maximal intercellular propagation of the noradrenaline signal from the periportal (upstream) area, where it is received from sympathetic nerve endings, to perivenous (downstream) hepatocytes. In connexin32-defective liver, the amount of connexin26 protein expressed was found to be lower than in wild-type liver, and the total area of gap junction plaques was -1000-fold smaller than in wild-type liver. In contrast to patients with connexin32 defects suffering from X chromosome-linked Charcot-Marie-Tooth disease (CMTX) due to demyelination in Schwann cells of peripheral nerves, connexin32-deficient mice did not show neurological abnormalities when analyzed at 3 months of age. It is possible, however, that they may develop neurodegenerative symptoms at older age.

No abstract

The properties of astroglial gap junction channels and the protein that constitutes the channels were characterized by immunocytochemical, molecular biological, and physiological techniques. Comparative immunocytochemical labeling utilizing different antibodies specific for liver connexin 32 and connexin 26 and antibodies to peptides corresponding to carboxy-terminal sequences of the heart gap junction protein (connexin 43) indicates that the predominant gap junction protein in astrocytes is connexin 43. The expression of this connexin in cultured astrocytes was also established by Western and Northern blot analyses. Cultured astrocytes expressed connexin 43 mRNA and did not contain detectable levels of the mRNAs encoding connexin 32 or connexin 26. Further, the cells contained the same primary connexin 43 translation product and the same phosphorylated forms as heart. Finally, electrophysiological recordings under voltage-clamp conditions revealed that astrocyte cell pairs were moderately well coupled, with an average junctional conductance of about 13 nS. Single-channel recordings indicated a unitary junctional conductance of about 50-60 pS, which is of the same order as that found in cultured rat cardiac myocytes, where the channel properties of connexin 43 were first described. Thus, physiological properties of gap junction channels appear to be determined by the connexin expressed, independent of the tissue type.

No abstract